Novio Catalpa is developing a completely new test to diagnose Rheumatoid arthritis at an early stage. The current method of diagnostics that delivers reliable results, the ‘Golden standard’, is expensive and involves sophisticated laboratory infrastructure.
Our test will identify anti-bodies in the blood of the patient. The specificity and sensitivity rates of the test will be comparable with the current golden standard.
Characteristics we are aiming for in the development of the test are:
Our goal is to develop a cost-effective and reliable diagnostic test that is widely accessible for the fast growing number of persons with Rheumatoid arthritis. This includes countries around the world lacking sophisticated laboratory infrastructure.